CooperVision releases MiSight 6-year data

Article

6-year data on MiSight contact lenses

Paul Chamberlain, who serves as CooperVision’s director of research programs, myopia, spoke with Optometry Times® Editor in Chief Gretchyn Bailey about the company’s 6-year data on MiSight contact lenses. Chamberlain discussed clinical implications of the data and next steps for following children wearing the daily disposable myopia management contact lenses.

Related: Review clinical highlights of new myopia control lens

Related: Sarah Michelle Gellar looks to slay myopia in MiSight campaign

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders what she would like to see develop as both a researcher and a clinician in the dry eye space.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Karl Stonecipher ASCRS 2025
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Related Content
Aldeyra submits third reproxalap New Drug Application for the treatment of dry eye disease - ©naka—stock.adobe.com

Aldeyra submits third reproxalap New Drug Application for the treatment of dry eye disease

Martin David Harp, Editor, Ophthalmology Times
June 17th 2025
Article
You and Eye by Optometry Times with host Miriam Korik, OD

You and Eye: Myopia cannot be viewed as a specialty in today's practice setting

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 18th 2024
Podcast
European Commission approves low-dose atropine eye drop Ryjunea, Santen announces - Image credit: ©artjazz—stock.adobe.com

European Commission approves low-dose atropine eye drop Ryjunea, Santen announces

Hattie Hayes
June 5th 2025
Article
You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 9th 2024
Podcast
Woman administering eye drops Image credit: AdobeStock/AndreyPopov

Bausch + Lomb launch Blink Nourish Lubricating eye drops and Blink Boost Lubricating eye drops in the US for dry eye

Jordana Joy, Associate Editor
June 4th 2025
Article
iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia ©OHishi_Foto—stock.adobe.com

iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia

Emily Kaiser Maharjan, Assistant Managing Editor
June 4th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.